{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T11:39:32Z","timestamp":1794483572582,"version":"4.9.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA048892"],"award-info":[{"award-number":["R01DA048892"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.josat.2026.210025","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T06:13:34Z","timestamp":1779171214000},"page":"210025","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Organizational perspectives on barriers and facilitators to an integrated care model for opioid use disorder and serious injection-related infections"],"prefix":"10.1016","volume":"189","author":[{"given":"Hilary L.","family":"Surratt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle R.","family":"Lofwall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth O.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice C.","family":"Thornton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn Villacorta","family":"Cari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon L.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura C.","family":"Fanucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.josat.2026.210025_bb0005","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDccon2100012","article-title":"Can I safely discharge a patient with a substance use disorder home with a peripherally inserted central catheter?","volume":"1","author":"Appa","year":"2022","journal-title":"NEJM Evidence"},{"issue":"14","key":"10.1016\/j.josat.2026.210025_bb0010","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001090","article-title":"Management of infective endocarditis in people who inject drugs: A scientific statement from the American Heart Association","volume":"146","author":"Baddour","year":"2022","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.josat.2026.210025_bb0015","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","article-title":"Infective endocarditis in adults: Diagnosis, antimicrobial therapy, and management of complications: A scientific statement for healthcare professionals from the American Heart Association","volume":"132","author":"Baddour","year":"2015","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.josat.2026.210025_bb0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qualitative Research in Psychology"},{"issue":"12","key":"10.1016\/j.josat.2026.210025_bb0025","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1377\/hlthaff.2024.00600","article-title":"Promoting access to hospital care in rural areas: Current approaches and ongoing challenges","volume":"43","author":"Carroll","year":"2024","journal-title":"Health Affairs"},{"issue":"11","key":"10.1016\/j.josat.2026.210025_bb0030","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae613","article-title":"Management of people who inject drugs with serious injection-related infections in an outpatient setting: A scoping review","volume":"11","author":"Dalai","year":"2024","journal-title":"Open Forum Infectious Diseases"},{"key":"10.1016\/j.josat.2026.210025_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2024.209377","article-title":"The addiction consultation service for hospitalized patients with substance use disorder: An integrative review of the evidence","volume":"163","author":"Danovitch","year":"2024","journal-title":"Journal of Substance Use and Addiction Treatment"},{"key":"10.1016\/j.josat.2026.210025_bb0040","doi-asserted-by":"crossref","DOI":"10.1007\/s11606-022-07618-x","article-title":"A taxonomy of hospital-based addiction care models: A scoping review and key informant interviews","author":"Englander","year":"2022","journal-title":"Journal of General Internal Medicine"},{"issue":"1","key":"10.1016\/j.josat.2026.210025_bb0045","doi-asserted-by":"crossref","DOI":"10.1186\/s13722-024-00461-x","article-title":"Contextual barriers and enablers to establishing an addiction-focused consultation team for hospitalized adults with opioid use disorder","volume":"19","author":"Evans","year":"2024","journal-title":"Addiction Science & Clinical Practice"},{"key":"10.1016\/j.josat.2026.210025_bb0050","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jsat.2018.06.011","article-title":"In-hospital illicit drug use, substance use disorders, and acceptance of residential treatment in a prospective pilot needs assessment of hospitalized adults with severe infections from injecting drugs","volume":"92","author":"Fanucchi","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2026.210025_bb0055","doi-asserted-by":"crossref","DOI":"10.1177\/20499361221108005","article-title":"Design and protocol of the Buprenorphine plus Outpatient Parenteral Antimicrobial Therapy (B-OPAT) study: A randomized clinical trial of integrated outpatient treatment of opioid use disorder and severe, injection-related infections","volume":"9","author":"Fanucchi","year":"2022","journal-title":"Therapeutic Advances in Infectious Disease"},{"key":"10.1016\/j.josat.2026.210025_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2019.105760","article-title":"Integrated outpatient treatment of opioid use disorder and injection-related infections: A description of a new care model","volume":"128","author":"Fanucchi","year":"2019","journal-title":"Preventive Medicine"},{"issue":"6","key":"10.1016\/j.josat.2026.210025_bb0065","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1093\/cid\/ciz654","article-title":"Outpatient parenteral antimicrobial therapy plus buprenorphine for opioid use disorder and severe injection-related infections","volume":"70","author":"Fanucchi","year":"2020","journal-title":"Clinical Infectious Diseases"},{"issue":"4","key":"10.1016\/j.josat.2026.210025_bb0070","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1553-7250(08)34030-6","article-title":"A Practical, Robust Implementation and Sustainability Model (PRISM) for integrating research findings into practice","volume":"34","author":"Feldstein","year":"2008","journal-title":"The Joint Commission Journal on Quality and Patient Safety"},{"issue":"1","key":"10.1016\/j.josat.2026.210025_bb0075","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/160940690600500107","article-title":"Demonstrating rigor using thematic analysis: A hybrid approach of inductive and deductive coding and theme development","volume":"5","author":"Fereday","year":"2006","journal-title":"International Journal of Qualitative Methods"},{"issue":"23","key":"10.1016\/j.josat.2026.210025_bb0080","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1001\/jama.2019.7377","article-title":"The rural hospital problem","volume":"321","author":"Frakt","year":"2019","journal-title":"Journal of the American Medical Association"},{"issue":"5","key":"10.1016\/j.josat.2026.210025_bb0085","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.11641","article-title":"Comparative effectiveness of long-acting lipoglycopeptides vs standard-of-care antibiotics in serious bacterial infections","volume":"8","author":"Goodman-Meza","year":"2025","journal-title":"JAMA Network Open"},{"issue":"1","key":"10.1016\/j.josat.2026.210025_bb0090","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1525822X05279903","article-title":"How many interviews are enough?: An experiment with data saturation and variability: An experiment with data saturation and variability","volume":"18","author":"Guest","year":"2006","journal-title":"Field Methods"},{"issue":"1","key":"10.1016\/j.josat.2026.210025_bb0095","doi-asserted-by":"crossref","DOI":"10.1186\/s13722-023-00363-4","article-title":"Implementation of an integrated infectious disease and substance use disorder team for injection drug use-associated infections: A qualitative study","volume":"18","author":"Hervera","year":"2023","journal-title":"Addiction Science & Clinical Practice"},{"key":"10.1016\/j.josat.2026.210025_bb0100","article-title":"Experiences of stigma in hospitals with addiction consultation services: A qualitative analysis of patients\u2019 and hospital-based providers\u2019 perspectives","volume":"138","author":"Hoover","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"7","key":"10.1016\/j.josat.2026.210025_bb0105","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.21740","article-title":"Medication for opioid use disorder after serious injection-related infections in Massachusetts","volume":"7","author":"Kimmel","year":"2024","journal-title":"JAMA Network Open"},{"issue":"1","key":"10.1016\/j.josat.2026.210025_bb0110","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"issue":"1","key":"10.1016\/j.josat.2026.210025_bb0115","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac708","article-title":"Methamphetamines and serious injection-related infections: Opioid use care continuum and opportunities to end Alabama\u2019s drug crisis","volume":"10","author":"Levy","year":"2022","journal-title":"Open Forum Infectious Diseases"},{"issue":"11","key":"10.1016\/j.josat.2026.210025_bb0120","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3390\/antibiotics14111103","article-title":"The impact of a structured Outpatient Parenteral Antimicrobial Therapy (OPAT) programme on quality of care, optimisation of antimicrobial use, and healthcare costs: A retrospective cohort study","volume":"14","author":"Manders","year":"2025","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.josat.2026.210025_bb0125","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.mcna.2021.08.006","article-title":"Infectious complications of injection drug use","volume":"106","author":"Marks","year":"2022","journal-title":"Medical Clinics of North America"},{"issue":"7","key":"10.1016\/j.josat.2026.210025_bb0130","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1093\/cid\/ciaa008","article-title":"Bacterial infections associated with substance use disorders, large cohort of United States hospitals, 2012\u20132017","volume":"71","author":"McCarthy","year":"2020","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"10.1016\/j.josat.2026.210025_bb0135","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: The kappa statistic","volume":"22","author":"McHugh","year":"2012","journal-title":"Biochemia Medica"},{"issue":"8","key":"10.1016\/j.josat.2026.210025_bb0140","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab289","article-title":"A systematic review and meta-analysis of studies evaluating the effect of medication treatment for opioid use disorder on infectious disease outcomes","volume":"8","author":"McNamara","year":"2021","journal-title":"Open Forum Infectious Diseases"},{"key":"10.1016\/j.josat.2026.210025_bb0145","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2024.3422","article-title":"Addiction consultation services for opioid use disorder treatment initiation and engagement: A randomized clinical trial","author":"McNeely","year":"2024","journal-title":"JAMA Internal Medicine"},{"issue":"10","key":"10.1016\/j.josat.2026.210025_bb0150","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac364","article-title":"\u201cThey just assume that we\u2019re all going to do the wrong thing with it. It\u2019s just not true\u201d: Stakeholder perspectives about peripherally inserted central catheters in people who inject drugs","volume":"9","author":"Morales","year":"2022","journal-title":"Open Forum Infectious Diseases"},{"issue":"2","key":"10.1016\/j.josat.2026.210025_bb0155","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa045","article-title":"Rural\u2013urban differences in hospitalizations for opioid use\u2013associated infective endocarditis in the United States, 2003\u20132016","volume":"7","author":"Nenninger","year":"2020","journal-title":"Open Forum Infectious Diseases"},{"key":"10.1016\/j.josat.2026.210025_bb0160","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2024.8586","article-title":"Hospital addiction consultation service and opioid use disorder treatment","author":"Ober","year":"2025","journal-title":"JAMA Internal Medicine"},{"issue":"1","key":"10.1016\/j.josat.2026.210025_bb0165","first-page":"1","article-title":"Intercoder reliability in qualitative research: Debates and practical guidelines","volume":"19","author":"O\u2019Connor","year":"2020","journal-title":"International Journal of Qualitative Methods"},{"key":"10.1016\/j.josat.2026.210025_bb0170","doi-asserted-by":"crossref","DOI":"10.1177\/20499361231192771","article-title":"Taking the route less traveled: On the way to COpAT","volume":"10","author":"Pertzborn","year":"2023","journal-title":"Therapeutic Advances in Infectious Disease"},{"issue":"Supplement_5","key":"10.1016\/j.josat.2026.210025_bb0175","doi-asserted-by":"crossref","first-page":"S494","DOI":"10.1093\/infdis\/jiaa025","article-title":"Feasibility and safety of outpatient parenteral antimicrobial therapy in conjunction with addiction treatment for people who inject drugs","volume":"222","author":"Price","year":"2020","journal-title":"The Journal of Infectious Diseases"},{"issue":"7","key":"10.1016\/j.josat.2026.210025_bb0180","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy132","article-title":"Infectious diseases physicians\u2019 perspectives regarding injection drug use and related infections, United States, 2017","volume":"5","author":"Rapoport","year":"2018","journal-title":"Open Forum Infectious Diseases"},{"issue":"4","key":"10.1016\/j.josat.2026.210025_bb0185","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlae111","article-title":"Outpatient parenteral antimicrobial therapy (OPAT) across the world: A comparative analysis-what lessons can we learn?","volume":"6","author":"Reidy","year":"2024","journal-title":"JAC-Antimicrobial Resistance"},{"issue":"1","key":"10.1016\/j.josat.2026.210025_bb0190","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-017-2031-8","article-title":"Acceptability of healthcare interventions: An overview of reviews and development of a theoretical framework","volume":"17","author":"Sekhon","year":"2017","journal-title":"BMC Health Services Research"},{"key":"10.1016\/j.josat.2026.210025_bb0195","doi-asserted-by":"crossref","first-page":"106394","DOI":"10.1016\/j.cct.2021.106394","article-title":"Design and methods of a multi-site randomized controlled trial of an integrated care model of long-acting injectable buprenorphine with infectious disease treatment among persons hospitalized with infections and opioid use disorder","volume":"105","author":"Seval","year":"2021","journal-title":"Contemporary Clinical Trials"},{"issue":"7","key":"10.1016\/j.josat.2026.210025_bb0200","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad372","article-title":"Perspectives on the use of outpatient parenteral antibiotic therapy for people who inject drugs: Results from an online survey of infectious diseases clinicians","volume":"10","author":"Solomon","year":"2023","journal-title":"Open Forum Infectious Diseases"},{"issue":"7","key":"10.1016\/j.josat.2026.210025_bb0205","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5055\/jom.2023.0799","article-title":"Advocacy for patients with opioid use disorder: A primer for physicians and other clinicians on the Americans with disabilities act","volume":"19","author":"South","year":"2023","journal-title":"Journal of Opioid Management"},{"key":"10.1016\/j.josat.2026.210025_bb0210","article-title":"Efficacy of clinician education on the Americans with Disabilities Act for people with opioid use disorder-a prospective study","author":"South","year":"2025","journal-title":"Journal of Addiction Medicine"},{"issue":"7","key":"10.1016\/j.josat.2026.210025_bb0215","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.21640","article-title":"Serious opioid injection-related infection and initiation of medication for opioid use disorder","volume":"7","author":"Springer","year":"2024","journal-title":"JAMA Network Open"},{"issue":"Supplement_5","key":"10.1016\/j.josat.2026.210025_bb0220","doi-asserted-by":"crossref","first-page":"S230","DOI":"10.1093\/infdis\/jiz673","article-title":"Federal and state action needed to end the infectious complications of illicit drug use in the United States: IDSA and HIVMA\u2019s advocacy agenda","volume":"222","author":"Springer","year":"2020","journal-title":"The Journal of Infectious Diseases"},{"issue":"9","key":"10.1016\/j.josat.2026.210025_bb0225","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1001\/jama.2025.4288","article-title":"Management of Staphylococcus aureus bacteremia: A review","volume":"334","author":"Tong","year":"2025","journal-title":"Journal of the American Medical Association"},{"issue":"4","key":"10.1016\/j.josat.2026.210025_bb0230","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaf108","article-title":"Prevalence of injection-related bacterial and fungal infection among people who inject drugs: A systematic review and meta-analysis","volume":"12","author":"Wheeler","year":"2025","journal-title":"Open Forum Infectious Diseases"},{"issue":"9","key":"10.1016\/j.josat.2026.210025_bb0235","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1093\/jac\/dkae177","article-title":"Current practices and challenges of outpatient parenteral antimicrobial therapy: A narrative review","volume":"79","author":"Wolie","year":"2024","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"14","key":"10.1016\/j.josat.2026.210025_bb0240","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.jacc.2024.01.034","article-title":"Strategies to improve patient-centered care for drug use-associated infective endocarditis","volume":"83","author":"Wurcel","year":"2024","journal-title":"Journal of the American College of Cardiology"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926001451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926001451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T11:10:43Z","timestamp":1794481843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875926001451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":48,"alternative-id":["S2949875926001451"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2026.210025","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Organizational perspectives on barriers and facilitators to an integrated care model for opioid use disorder and serious injection-related infections","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2026.210025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"210025"}}